Most Recent
The Australian Competition and Consumer Commission has dropped a consumer case accusing NIB Health Funds of failing to alert customers to coverage changes in their policies, less than a month before trial was set to kick off in the long-running case.
Two insurers have appealed a ruling that could provide a further $11.25 million to group members in a class action against sandalwood producer Quintis, further delaying finalisation of a settlement reached in the group proceeding over a year ago.
AGL Energy has dragged Greenpeace Australia Pacific to court for using its logo in a campaign that labelled the company "Australia's biggest climate polluter" and accused it of "significant environmental breaches".
The Australian Competition and Consumer Commission is seeking leave to intervene in Epic Games' appeal of a ruling that sent its misuse of market power lawsuit against Apple to California so that it can argue the case should be heard in Australia.
The ABC has come out swinging in its defence to former attorney-general Christian Porter's lawsuit over an allegedly defamatory article concerning historical rape allegations, saying there were reasonable grounds for suspecting Porter brutally raped a girl when they were teenagers and that it had a duty to publish the article.
The Corner Hotel is taking another stab at cancelling a rival club's 'jazz corner' and 'jazz corner hotel trade marks', after a judge found the marks did not infringe the famed Richmond pub's 'corner' trade marks.
Former attorney-general Christian Porter is seeking to block the public from seeing portions of the ABC's defence to claims that it defamed him with an article detailing historical rape allegations.
A mid-trial settlement has been reached in a lawsuit brought by the liquidators of collapsed steel giant Arrium against 10 former company directors and officers for allegedly engaging in insolvent trading.
Generic drug company Pharmacor has fired back in a patent lawsuit by Novartis, filing a cross-claim seeking to invalidate the Swiss drug giant's patents for its blockbuster MS drug Gilenya.
Telstra has been hit with a $1.5 million fine from the the Australian Communications and Media Authority for dropping its number porting service during the first COVID-19 wave last year, leaving 42,000 customers unable to transfer their numbers away from or to new providers.